DeutschNewstral
Article
Ddcourier.com on 2023-08-01 19:38
Merck Posts Narrower-Than Expected Loss, Lifts Sales Outlook on Keytruda Boost
Related news
- DMerck Posts Narrower Loss, Lifts Sales Forecast On Keytruda Boostdcourier.com
Merck beats expectations, helped by Keytruda salesdailyherald.com- HMerck Scores a Hit With Keytruda, Watches Spending in 4Qhamodia.com
Merck scores a hit with Keytruda, watches spending in 4Qthenewstribune.com- BMerck Delivers on Earnings as Sales of Cancer Drug Keytruda Soarbarrons.com
- TPfizer posts narrower Q3 loss amid slumping Covid vaccine salesthestreet.com
How Important Is Keytruda For Merck?Forbes- HA Strong 2Q for Merck, Outlook Mixedhamodia.com
- AA strong 2Q for Merck, outlook mixedapnewsarchive.com
- BMerck Stock Climbs on Earnings Beat as Keytruda Sales Jumpbarrons.com
- TMicron surges on outlook for AI-powered-chip sales and narrower Q1 lossthestreet.com
Drugmaker Merck tops 3Q forecasts as Keytruda sales jump 20%Seattle Times- Merck Maintaining Its Lofty Valuation Due To Keytruda MomentumForbes
- MMerck announces positive results for Keytruda in melanoma trialmarketwatch.com
- MMerck stock rises 2.4% after new Keytruda lung cancer approvalmarketwatch.com
- MMerck shares slip as Keytruda fails another clinical trialmarketwatch.com
- Merck posts strong first-quarter profit, but revenue lightthenewstribune.com